ArticleIndian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine2026
Validation of Point-of-care Testing Device HemoCue® Glucose 201RT in Blood Glucose Estimation.
Article in Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: We aimed to conduct this study to compare the validity of the HemoCue® Glucose 201 RT System (point-of-care testing (POCT) device) in estimating blood glucose levels in patients attending a tertiary care hospital, considering the automated analyzer method (Vitros® 4600 chemistry system, QuidelOrtho Corporation, USA) as the gold standard. Methods: We conducted this study among the patients attending the outpatient department in a tertiary care hospital in Eastern India. Venous blood was collected to estimate fasting blood glucose (FBS) and postprandial blood glucose (PPBS) using the automated analyzer and the POCT device, along with capillary blood to estimate FBS and PPBS using the POCT device. Results: We enrolled 200 patients with a mean age of 49.4 (standard deviation 12.6) years. Lin's CCC for POCT device compared to automated analyzer (venous blood) for FBS estimation was 0.95 (95% confidence interval (CI): 0.94 to 0.96, Conclusion: The POCT device showed substantial concordance with the gold standard method for measuring both FBS and PPBS. It also demonstrated a fair agreement with the automated analyzer in estimating blood glucose levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.